251 related articles for article (PubMed ID: 29666556)
1. Maturity onset diabetes of the young due to
Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
[TBL] [Abstract][Full Text] [Related]
2. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
[TBL] [Abstract][Full Text] [Related]
3. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
[TBL] [Abstract][Full Text] [Related]
4. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
[TBL] [Abstract][Full Text] [Related]
5. Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult-Onset Nonautoimmune Diabetes.
Juszczak A; Pavić T; Vučković F; Bennett AJ; Shah N; Pape Medvidović E; Groves CJ; Šekerija M; Chandler K; Burrows C; Rojnić Putarek N; Vučić Lovrenčić M; Ćuća Knežević J; James TJ; Gloyn AL; Lauc G; McCarthy MI; Owen KR; Gornik O
Diabetes Care; 2019 Jan; 42(1):17-26. PubMed ID: 30455330
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.
Pihoker C; Gilliam LK; Ellard S; Dabelea D; Davis C; Dolan LM; Greenbaum CJ; Imperatore G; Lawrence JM; Marcovina SM; Mayer-Davis E; Rodriguez BL; Steck AK; Williams DE; Hattersley AT;
J Clin Endocrinol Metab; 2013 Oct; 98(10):4055-62. PubMed ID: 23771925
[TBL] [Abstract][Full Text] [Related]
7. Low genetic confirmation rate in South Indian subjects with a clinical diagnosis of maturity-onset diabetes of the young (MODY) who underwent targeted next-generation sequencing for 13 genes.
Sampathkumar G; Valiyaparambil PP; Kumar H; Bhavani N; Nair V; Menon U; Menon A; Abraham N; Chapla A; Thomas N
J Endocrinol Invest; 2022 Mar; 45(3):607-615. PubMed ID: 34741762
[TBL] [Abstract][Full Text] [Related]
8. Unsupervised Clustering of Missense Variants in HNF1A Using Multidimensional Functional Data Aids Clinical Interpretation.
Althari S; Najmi LA; Bennett AJ; Aukrust I; Rundle JK; Colclough K; Molnes J; Kaci A; Nawaz S; van der Lugt T; Hassanali N; Mahajan A; Molven A; Ellard S; McCarthy MI; Bjørkhaug L; Njølstad PR; Gloyn AL
Am J Hum Genet; 2020 Oct; 107(4):670-682. PubMed ID: 32910913
[TBL] [Abstract][Full Text] [Related]
9. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
Owen KR; Thanabalasingham G; James TJ; Karpe F; Farmer AJ; McCarthy MI; Gloyn AL
Diabetes Care; 2010 Sep; 33(9):1919-24. PubMed ID: 20724646
[TBL] [Abstract][Full Text] [Related]
10. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes.
Svalastoga P; Kaci A; Molnes J; Solheim MH; Johansson BB; Krogvold L; Skrivarhaug T; Valen E; Johansson S; Molven A; Sagen JV; Søfteland E; Bjørkhaug L; Tjora E; Aukrust I; Njølstad PR
Diabetologia; 2023 Dec; 66(12):2226-2237. PubMed ID: 37798422
[TBL] [Abstract][Full Text] [Related]
12. Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
Giuffrida FMA; Moises RS; Weinert LS; Calliari LE; Manna TD; Dotto RP; Franco LF; Caetano LA; Teles MG; Lima RA; Alves C; Dib SA; Silveiro SP; Dias-da-Silva MR; Reis AF;
Diabetes Res Clin Pract; 2017 Jan; 123():134-142. PubMed ID: 28012402
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
[TBL] [Abstract][Full Text] [Related]
14. Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?
Majidi S; Fouts A; Pyle L; Chambers C; Armstrong T; Wang Z; Batish SD; Klingensmith G; Steck AK
Diabetes Technol Ther; 2018 Feb; 20(2):106-112. PubMed ID: 29355436
[TBL] [Abstract][Full Text] [Related]
15. Molecular background and clinical characteristics of HNF1A MODY in a Polish population.
Skupien J; Gorczynska-Kosiorz S; Klupa T; Cyganek K; Wanic K; Borowiec M; Sieradzki J; Malecki MT
Diabetes Metab; 2008 Nov; 34(5):524-8. PubMed ID: 18838325
[TBL] [Abstract][Full Text] [Related]
16. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
Szopa M; Klupa T; Kapusta M; Matejko B; Ucieklak D; Glodzik W; Zapala B; Sani CM; Hohendorff J; Malecki MT; Skupien J
Endocrine; 2019 Apr; 64(1):75-81. PubMed ID: 30778899
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).
Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A
Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305
[TBL] [Abstract][Full Text] [Related]
18. Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes.
Lango Allen H; Johansson S; Ellard S; Shields B; Hertel JK; Raeder H; Colclough K; Molven A; Frayling TM; Njølstad PR; Hattersley AT; Weedon MN
Diabetes; 2010 Jan; 59(1):266-71. PubMed ID: 19794065
[TBL] [Abstract][Full Text] [Related]
19. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of maturity onset diabetes of the young in a large diabetes center.
Chambers C; Fouts A; Dong F; Colclough K; Wang Z; Batish SD; Jaremko M; Ellard S; Hattersley AT; Klingensmith G; Steck AK
Pediatr Diabetes; 2016 Aug; 17(5):360-7. PubMed ID: 26059258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
